Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02866422 · ClinicalTrials.gov registry record

Development of an Instrument That Monitors Behaviors Associated With OCD

A clinical trial of OCD, sponsored by University of Minnesota.

Completed
Registry status
40
Enrollment target
1
Study location

NCT02866422 is a study of OCD that has completed, run by University of Minnesota. The registered enrollment target is 40 participants, below the 816-participant average among 18 other OCD trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02866422, a study of OCD, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

To support the discovery of new means for revealing the presence of Obsessive Compulsive Disorder (OCD), facilitating detection through new technology-based metrics, and attempt to automate existing diagnostic procedures allowing for more efficient diagnostic methods that would broaden clinical scope and outreach.

Conditions Studied

OCD

Interventions

  • OTHER No Intervention

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2014-03
Est. Completion 2015-03

Sponsor

University of Minnesota

966 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02866422

The ClinicalTrials.gov registry entry for NCT02866422 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 18 other OCD trials with a reported enrollment target (95% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with OCD appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.

NCT02866422 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02866422 about?

NCT02866422 is a clinical study titled "Development of an Instrument That Monitors Behaviors Associated With OCD". To support the discovery of new means for revealing the presence of Obsessive Compulsive Disorder (OCD), facilitating detection through new technology-based metrics, and attempt to automate existing diagnostic procedures allowing for more efficient diagnostic methods that would broaden clinical scop...

What is the current status of trial NCT02866422?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-03. Estimated completion is 2015-03.

What conditions does trial NCT02866422 study?

This clinical trial studies the following conditions: OCD.

What interventions are being tested in trial NCT02866422?

The interventions under investigation include: No Intervention (OTHER).

Who is sponsoring clinical trial NCT02866422?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02866422 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for OCD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

OCD

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.